ZFP869 Inhibitors
Chemical inhibitors of ZFP869 can modulate its activity through various biochemical pathways. Phorbol 12-myristate 13-acetate (PMA) and Bryostatin 1 are both activators of Protein Kinase C (PKC), which can phosphorylate ZFP869, enhancing its DNA-binding activity or promoting its interaction with other transcriptional coactivators. Similarly, Ionomycin, by increasing intracellular calcium levels, can activate calcium-dependent kinases such as PKC, which can also result in the phosphorylation of ZFP869. In contrast, Okadaic Acid and Calyculin A inhibit protein phosphatases like PP1 and PP2A, preventing the dephosphorylation of ZFP869 and maintaining it in an active phosphorylated state. This inhibition can keep ZFP869 in a state that allows it to continuously act as a transcription factor without the regulatory check that dephosphorylation by phosphatases would provide.
Forskolin and related compounds such as 8-Br-cAMP and Dibutyryl cAMP increase cAMP levels in cells, which in turn activate Protein Kinase A (PKA). PKA can then phosphorylate ZFP869, potentially increasing its transcription factor activity by promoting its binding to DNA or recruitment of cofactors. PDBu, a PKC activator that mimics diacylglycerol (DAG), can lead to the phosphorylation of ZFP869, enhancing its transcriptional activity by promoting its nuclear localization or DNA-binding ability. Additionally, Anisomycin, which is a protein synthesis inhibitor, can activate stress-activated protein kinases (SAPKs) that can phosphorylate ZFP869, possibly enhancing its function by increasing its stability or DNA-binding activity. Lastly, Fusicoccin can potentiate ZFP869's activity by stabilizing the interaction between 14-3-3 proteins and phosphorylated ZFP869, which could enhance its function as a transcription factor.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates Protein Kinase C (PKC) which is known to phosphorylate a myriad of proteins. ZFP869 activation can result from PKC-mediated phosphorylation that enhances its DNA-binding activity or promotes its interaction with other coactivators. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin increases intracellular calcium levels, which can activate calcium-dependent kinases such as PKC. This activation can result in the phosphorylation of ZFP869, leading to an increase in its transcription factor activity. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic Acid inhibits protein phosphatases PP1 and PP2A. Inhibition of these phosphatases prevents dephosphorylation of ZFP869, maintaining it in an activated phosphorylated state, which may enhance its function as a transcription factor. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $126.00 $328.00 | 30 | |
8-Br-cAMP is a cAMP analog that activates PKA. Upon activation, PKA may phosphorylate ZFP869, potentially increasing its activity as a transcription factor by facilitating its binding to DNA or interaction with other proteins. | ||||||
Bryostatin 1 | 83314-01-6 | sc-201407 | 10 µg | $245.00 | 9 | |
Bryostatin 1 is a PKC activator that can promote the phosphorylation of ZFP869, potentially enhancing its activity as a transcription factor by increasing its DNA-binding activity or interaction with transcriptional machinery. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin is a protein synthesis inhibitor that can activate stress-activated protein kinases (SAPKs). These kinases can phosphorylate ZFP869, potentially enhancing its function by increasing its stability or DNA-binding activity. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin inhibits the SERCA pump, leading to increased cytosolic calcium levels, which can activate PKC. Activated PKC might phosphorylate ZFP869, potentially increasing its transcriptional activity. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Calyculin A inhibits protein phosphatases such as PP1 and PP2A. This inhibition can lead to the sustained phosphorylation of ZFP869, potentially keeping it in an activated state conducive to its role as a transcription factor. | ||||||
Phorbol-12,13-dibutyrate | 37558-16-0 | sc-202285 | 1 mg | $124.00 | 3 | |
PDBu is a PKC activator that can mimic diacylglycerol (DAG). It can lead to the phosphorylation of ZFP869, which might enhance its transcriptional activity by promoting its nuclear localization or DNA-binding ability. | ||||||
Fusicoccin | 20108-30-9 | sc-200754 sc-200754A sc-200754B | 1 mg 5 mg 10 mg | $416.00 $2081.00 $4162.00 | 7 | |
Fusicoccin stabilizes the interaction between 14-3-3 proteins and their phosphorylated partners. If ZFP869 interacts with 14-3-3 proteins upon phosphorylation, this stabilization could enhance its activity as a transcription factor. | ||||||